Lobular Breast Cancer Alliance Inc, operating under the name Lbca, is located in White Horse Beach, MA. According to its NTEE Classification (G32) the organization is classified as: Breast Cancer, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 06/2023, Lbca employed 5 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Lbca is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
EDUCATING THE MEDICAL & GENERAL PUBLIC ABOUT INVASIVE LOBULAR CARCINOMA (ILC)/LOBULAR BREAST CANCER, PROVIDING TRAINING & INFORMATION TO SUPPORT VOLUNTEERS SEEKING TO ADVOCATE FOR GREATER ILC AWARENESS AND MORE RESEARCH, PROMOTING PATIENT & RESEARCHER COLLABORATIONS, AND MAKING GRANTS FOR ILC RESEARCH.
Describe the Organization's Program Activity:
Part 3 - Line 4a
DURING THE FISCAL YEAR, LBCA:- MANAGED WEBSITE WITH OVER 42,000 VISITS THAT PROVIDES DETAILED INFORMATION FOR THE PUBLIC ABOUT INVASIVE LOBULAR BREAST CANCER (ILC), ILC RESEARCH, CLINICAL TRIALS AND PATIENT ADVOCACY OPPORTUNITIES;- PRODUCED ILC AWARENESS-RAISING VIDEOS AND INTERVIEWS OF ILC RESEARCHERS.- PUBLISHED ILC FAQS AND FACT SHEETS IN 15 LANGUAGES, A "QUESTIONS FOR DOCTOR" GUIDE FOR ILC PATIENTS, AND A MONTHLY E-NEWSLETTER WITH OVER 5,200 SUBSCRIBERS;- PRESENTED ABSTRACT POSTER OF METASTATIC ILC PATIENT SURVEY RESULTS AT SABCS22, THE LARGEST US BREAST CANCER RESEARCH SYMPOSIUM; - FUNDED ILC RESEARCH GRANTS WITH THE SOCIETY OF (CONT'D IN SCHEDULE O) NUCLEAR MEDICINE AND MOLECULAR IMAGING AND THE AMERICAN ASSOCIATION FOR CANCER RESEARCH;-CREATED CAMPAIGN WITH APPROX. 24 OTHER NONPROFIT CANCER ORGANIZATIONS TO INCREASE PUBLIC AWARENESS THAT BREAST CANCER HAS SUBTYPES;- HOSTED WEBINARS FOR ILC PATIENT ADVOCATES ON RESEARCH AND OTHER TOPICS, AND SPONSORED VOLUNTEER PATIENT ADVOCATE ATTENDANCE AT BREAST CANCER CONFERENCES;- SPONSORED SCIENTIFIC ADVISORY BOARD MEETINGS TO INVOLVE ILC RESEARCHERS IN ADVOCACY AND IN THE DEVELOPMENT OF INFORMATION LBCA DISSEMINATES;- SPONSORED PATIENT ADVOCATE ADVISORY BOARD MEETINGS TO INVOLVE ILC PATIENT ADVOCATES IN ILC AWARENESS RAISING ACTIVITIES AND STRATEGIC PLANNING;- DEVELOPED AND SHARED ON WEBSITE AND SOCIAL MEDIA LAY SUMMARIES OF ALL ILC POSTERS PRESENTED AT SABCS22, TO MAKE THE RESEARCH PRESENTED ACCESSIBLE TO LAY AUDIENCES;- DEVELOPED SURVEY OF RADIOLOGISTS REGARDING ILC PATIENT IMAGING WITH THE SOCIETY OF BREAST IMAGERS;-FURNISHED ILC-RELATED INFORMATION TO THE AMERICAN CANCER SOCIETY, BREASTCANCER.ORG AND OTHER ORGANIZATIONS TO INCLUDE IN THEIR EDUCATIONAL CONTENT AND ACTIVITIES; AND-CO-AUTHORED AN ABSTRACT ABOUT HOW ILC IS AN OVERLOOKED SUBTYPE IN CLINICAL TRIALS, PUBLISHED IN THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY ESMO OPEN SPECIAL ISSUE.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Laurie B Hutcheson Ms President, Ed, & Director | OfficerTrustee | 50 | $110,000 |
Mason Mitchell-Daniels Msw MPH Vice President & COO | Officer | 20 | $43,563 |
Rachel Jankowitz MD Director (until 9/2022) | Trustee | 1 | $0 |
Tanya Martin-Dick Director | Trustee | 1 | $0 |
Ramlah Nehring PHD Director | Trustee | 1 | $0 |
Deborah Mueller MD Director (until 2/2023) | Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $599,316 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $599,316 |
Total Program Service Revenue | $0 |
Investment income | $265 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $599,581 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $131,500 |
Grants and other assistance to domestic individuals. | $5,140 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $156,861 |
Compensation of current officers, directors, key employees. | $21,625 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $89,080 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $20,199 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $24,343 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $63,386 |
Advertising and promotion | $885 |
Office expenses | $297 |
Information technology | $6,879 |
Royalties | $0 |
Occupancy | $0 |
Travel | $5,077 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $510 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $2,952 |
All other expenses | $0 |
Total functional expenses | $526,217 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $16,812 |
Savings and temporary cash investments | $312,806 |
Pledges and grants receivable | $49,139 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $1,631 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $380,388 |
Accounts payable and accrued expenses | $82,111 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $82,111 |
Net assets without donor restrictions | $298,277 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $380,388 |
Over the last fiscal year, Lobular Breast Cancer Alliance Inc has awarded $131,500 in support to 3 organizations.
Grant Recipient | Amount |
---|---|
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING PURPOSE: TO FUND IMAGING RESEARCH FELLOWSHIP | $60,000 |
AMERICAN ASSOCIATION FOR CANCER RESEARCH PURPOSE: TO FUND RESEARCH FELLOWSHIP | $70,000 |
NATIONAL BREAST CANCER COALITION PURPOSE: SUPPORT PATIENT ADVOCATE TRAINING PROGRAM | $1,500 |